Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.

Tarsus Pharmaceuticals

Talent Development Manager

Associate Director, Talent Development

Volterra is a distributed cloud services company.

Volterra is a distributed cloud services company. It was founded in 2017 and is based in Santa Clara, California.

Volterra

Crescendo Networks accelerates and optimizes the delivery of business-critical web applications via application delivery controllers.

Crescendo Networks accelerates and optimizes delivery of business-critical Web applications through the market√¢‚Ç¨‚Ñ¢s best-performing application delivery controllers. A purpose-built hardware design with a massively parallel architecture enables Crescendo√¢‚Ç¨‚Ñ¢s ADCs to outperform competing products under peak load with all features turned on, allowing servers to serve user requests even under massive HTTP traffic or extreme load. The company√¢‚Ç¨‚Ñ¢s products are used by many of the world√¢‚Ç¨‚Ñ¢s most sophisticated and fastest-growing Web properties to ensure usability, facilitate rapid business growth, lower IT costs and capture additional revenue.

Crescendo Networks

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company‚Äôs cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte‚Äôs proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. In addition to its pneumococcal conjugate vaccines in development, VAX-24 and VAX-XP, Vaxcyte is leveraging its proprietary platform to advance other novel vaccines, including a prophylactic vaccine to prevent Group A Strep infections (VAX-A1) and a therapeutic vaccine to treat periodontal disease (VAX-PG).

Vaxcyte

Manager, Talent Development

Harry's is a developer of an online platform used to sell shaving equipment and accessories for men.

Harry's is a developer of an online platform used to sell shaving equipment and accessories for men. It designs and manufactures its own line of razors and replacement blades, as well as other shaving consumables, and offers its products a-la-carte via its online store or through a subscription model that enables consumers to meet their grooming essentials need online. The company was founded in 2013 and is headquartered in New York.

Location

Company Stage

Age of Data

Experience

Industry

Company

Talent Development Manager

Tarsus Pharmaceuticals

$143k - $200k

$142,500 - $199,500

Volterra

$119k - $179k

$119,293 - $178,939

Crescendo Networks

$119k - $179k

$119,293 - $178,939

Vaxcyte

$140k - $155k

$140,000 - $155,000

Harry's

$115k - $138k

$114,500 - $137,500

gtmfund

$15k

$15,000